FDA Chief Marty Makary Resigns, Leaving Food and Safety Agenda in Limbo as Kyle Diamantas Takes Over
Updated
Updated · WJLA · May 12
FDA Chief Marty Makary Resigns, Leaving Food and Safety Agenda in Limbo as Kyle Diamantas Takes Over
27 articles · Updated · WJLA · May 12
Marty Makary left the FDA on May 12, abruptly stalling investigations and proposed standards on baby food safety, chemical exposure limits and other public-health initiatives.
His tenure pushed the agency beyond its traditional drug-regulator role toward obesity, food additives, environmental toxins and a broader "food is medicine" agenda, drawing resistance inside and outside the FDA.
Kyle Diamantas, who led the FDA's food division, is expected to serve as acting commissioner, but no permanent successor has been named.
Trump had already approved plans to oust Makary after dissatisfaction over flavored-vape policy and a delayed mifepristone review, raising the prospect that the next commissioner could take a more industry-friendly line.
With public trust falling, can new leadership fix the FDA's internal chaos and restore faith in its scientific judgment?
Will the FDA's leadership change end the regulatory uncertainty that has delayed new medicines and shaken the biopharma industry?